Sign Out
Patients with cardiogenic shock or those with NYHA (New York Heart Association) Class IV decompensated heart failure requiring IV inotropic support.
Patients with respiratory disease such as asthma and Chronic Obstructive Pulmonary Disease (COPD) with a bronchospastic component.
Patients with secondary hypertension.
Patients with acute pulmonary arterial embolism.
Patients who especially stimulate or block cardiac conduction such as 2nd- and 3rd-degree AV block, sick-sinus syndrome and sinoatrial block.
Patients with severe bradycardia.
Patients with metabolic acidosis.
Patients taking MAO inhibitor (excluding MAO-B inhibitor).
Patients with severe hypotension (systolic blood pressure <90 mmHg).
Patients with hypersensitivity to this drug.
Patients with hepatic impairment.
Patients with acute myocardial infarction within 4 weeks after onset of disease.
Patients with sick sinus syndrome.
Continue with Google